期刊
APMIS
卷 128, 期 5, 页码 353-366出版社
WILEY
DOI: 10.1111/apm.13038
关键词
Atherosclerosis; cardiovascular disease; gut microbiota; microbial metabolites; trimethylamine N-oxide
资金
- Important Weak Subject Construction Project of Pudong Health and Family Planning Commission of Shanghai [PWZbr2017-06]
- Scientific Research Project of Shanghai Municipal Health and Family Planning Commission [20184Y0213]
The increasing prevalence of cardiovascular diseases cannot adequately be explained by traditional risk factors. Recently, accumulating evidence has suggested that gut microbiota-derived numerous metabolites are contributors to atherosclerotic events. Among them, the role of trimethylamine N-oxide (TMAO) in promoting atherosclerosis has gained attention. TMAO is reported to exert the proatherogenic effects by impacting on the traditional risk factors of atherosclerosis and is associated with high risk of cardiovascular events. Besides that, TMAO is involved in the complex pathological processes of atherosclerotic lesion formation, such as endothelial dysfunction, platelet activation and thrombus generation. In light of these promising findings, TMAO may serve as a potential target for atherosclerosis prevention and treatment, which is conceptually novel, when compared with existing traditional treatments. It is likely that regulating TMAO production and associated gut microbiota may become a promising strategy for the anti-atherosclerosis therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据